----
Current ValuationThe current P/E ratio is 3.57, below the reasonable range, cheaper than 99.85% of the time in the past 5 years, and the industry ranks 3/78, the industry Median -4.79.
3.57xP/E
HK$13.54Stock price
HK$3.79Earnings per share
3.57xP/E
Stock priceHK$13.54Earnings per shareHK$3.79
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 8.55x
- Typical range
- 6.86x–12.28x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
0146292438584
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
09995HKREMEGEN | 4.81x | 490.89% | HK$36.61B |
01530HK3SBIO | 3.57x | 71.64% | HK$34.03B |
09969HKINNOCARE | 12.52x | 3.30% | HK$19.88B |
02142HKHBM HOLDINGS-B | 12.81x | 8.46% | HK$8.49B |
01167HKJACOBIO-B | 6.08x | -- | HK$3.60B |
02509HKQYUNS-B | 5.44x | 23.95% | HK$3.42B |
06998HKEDDING GENOR | 12.66x | -- | HK$3.19B |
02197HKCLOVER BIO-B | 1.66x | -- | HK$1.62B |
01061HKESSEX BIO-TECH | 4.45x | 1.60% | HK$1.18B |
02566HKJIUYUAN GENE | 7.33x | -- | HK$1.18B |
00690HKUNI-BIO GROUP | 8.12x | -- | HK$394.10M |
08158HKCRMI | 2.71x | -- | HK$74.54M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
